Advertisement

Topics

O'Reilly Media, Inc. Company Profile

23:43 EST 16th December 2018 | BioPortfolio

O'Reilly Media was originally a technical writing consulting company named O'Reilly & Associates. In 1984, we started retaining rights to manuals we created for Unix vendors. Our books were grounded in our hands-on experience with the technology, and we wrote them in a straightforward, conversational voice. We weren't afraid to say in print that a vendor's technology didn't work as advertised. While our publishing program has expanded to include everything from digital photography to desktop applications to software engineering, those early principles still guide our editorial approach.We were early users of the internet. After the publication of our first million- copy bestseller, Ed Krol's The Whole Internet User's Guide & Catalog, we developed our first online product, a version of the internet catalog from the book. That product, the Global Network NavigatorTM (GNN), was the first web portal. In addition to being the first exclusively web-based publication, GNN pioneered the advertiser-supported model of online publishing. We sold GNN to America Online in June 1995.
Today, our online offerings present technology information in a range of formats. Our portal for developers, the O'Reilly Network (www.oreillynet.com), focuses on open and emerging technologies, covering important new technologies in the trademark O'Reilly style-- independent and in-depth--and steeped in the experience of those on the "bleeding edge." Our O'Reilly Radar blog (radar.oreilly.com), written by a team of O'Reilly technologists, presents intelligence about emerging technology and highlights the original research conducted by the O'Reilly Research group. CodeZoo (www.codezoo.com) offers a repository of open source components, plus a rich mix of related information from O'Reilly and the developer community.

Location

1005 Gravenstein Highway North
Sebastopol
California
95472
United States of America

Contact

Phone: (707) 827-7000 / (800) 998-9938
Fax: (707) 829-0104
Email: information@oreilly.co.uk


News Articles [430 Associated News Articles listed on BioPortfolio]

INVESTOR ALERT: Ademi O'Reilly, LLP Investigates Whether The Boeing Company (BA) Violated ...

MILWAUKEE, Nov. 16, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP announces an investigation of The Boeing Company (BA) for possible violations of securities laws. If Read more...

INVESTOR ALERT: Ademi O'Reilly, LLP Investigates Whether Goldman Sachs (GS) Violated Securities Laws

MILWAUKEE, Nov. 16, 2018 /PRNewswire/ -- Ademi & O'Reilly, LLP announces an investigation of Goldman Sachs (GS) for possible violations of securities laws. If you Read more...

It’s time! Check out Lori Reilly at @AtlanticLIVE ’s #PeopleVCancer as she discusses the future of cancer medicines with Steven Benner of @AstellasUS. Livestream: http://bit.ly/2z8WA6D  #GoBoldlypic.twitter.com/aNQBPo4scg

It’s time! Check out Lori Reilly at @AtlanticLIVE ’s #PeopleVCancer as she discusses the future of cancer medicines with Steven Benner of @AstellasUS. Livestream: http://bit.ly/2z8WA6...

What’s is the future of cancer treatment? Tomorrow in NYC, our own Lori Reilly and Steven Benner of @AstellasUS will discuss taking on challenges in oncology through personalized medicine. More on #PeopleVCancer here: http://bit.ly/2PrvK3P  #GoBoldl

What’s is the future of cancer treatment? Tomorrow in NYC, our own Lori Reilly and Steven Benner of @AstellasUS will discuss taking on challenges in oncology through personalized medicine. Mor...

.@PhRMA’s Lori Reilly underscores promise of outcomes-based payments (despite regulatory hurdles), biopharma’s commitment to providing patients with meaningful info on costs #PeopleVCancerpic.twitter.com/qYl2m3G8WC

. @PhRMA’s Lori Reilly underscores promise of outcomes-based payments (despite regulatory hurdles), biopharma’s commitment to providing patients with meaningful info on costs #PeopleVCanc...

Did you know there are more than 340 medicines in development for blood cancers? Tomorrow, our own Lori Reilly and Steven Benner of @AstellasUS are discussing the future of cancer medicine. For more on #PeopleVCancer, check out http://bit.ly/2RSJ3qK  #G

Did you know there are more than 340 medicines in development for blood cancers? Tomorrow, our own Lori Reilly and Steven Benner of @AstellasUS are discussing the future of cancer medicine. For more ...

Opsona Therapeutics Ltd. to Present Results on Tomaralimab Study at the 60th Annual Meeting of ...

Opsona TherapeuticsMary Reilly (COO)+ 353 16770223mreilly@opsona.com Read more...

Mary O’Reilly Named New Flinn Foundation Vice President, Bioscience Research Programs

Mary O’Reilly, Ph.D., a philanthropy executive with extensive industry and laboratory experience, has been named the new Vice President, Bioscience Research Programs at the Flin...

PubMed Articles [628 Associated PubMed Articles listed on BioPortfolio]

Analyzing College Students' Social Media Communication Apprehension.

Research has shown that college students are heavy users of social media. Yet, very little has looked at the connection between college students' social media use and communication apprehension (CA). ...

Pre-Data Likelihood Ratios and Bayes Factor Upper Bounds - A Comment on Adams & O'Reilly (2017).

Recipes and Tools for Culture of Escherichia coli.

In this article, we provide information about culture media, including minimal liquid media, rich liquid media, solid media, top agar, and stab agar. We also provide descriptions and useful informatio...

Acne treatment: analysis of acne-related social media posts and the impact on patient care.

Many patients use social media as a source of medical information on dermatologic diseases. Social media offers accessible methods of communicating with physicians, other patients, and pharmacies. The...

Media reporting of suicide and adherence to media guidelines.

International research consistently shows evidence for an association between sensationalised and detailed media reporting, and suicidal behaviour.

Clinical Trials [506 Associated Clinical Trials listed on BioPortfolio]

Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children

Otitis media is one of the most common infections among children and is a complication in about 30% of common colds. The most common complication of acute otitis media is otitis media with...

Social-Media Intervention in Reducing Indoor Tanning in High-Risk Indoor Tanners

This randomized clinical trial studies how well social-media intervention works in reducing indoor tanning in high-risk indoor tanners. Social-media intervention delivered via Facebook may...

Testing a Community Intervention to Increase Aspirin Use

This research will test the effect of mass media or mass media plus a clinic based education program will improve appropriate aspirin use for cardiovascular disease prevention. It is a gro...

Impact of Pneumococcal Conjugate Vaccines on Otitis Media and Acute Otitis Media in Swedish Children

The goal of this study is to look at the effect of pneumococcal conjugate vaccines (PCV) on physician-diagnosed otitis media (OM) and acute otitis media (AOM) incidence in Swedish children...

Culture Media and Blastocyst Development

The aim of this non-interventional study is to compare the blastulation rate per fertilized oocyte in two different single step culture media commercially available (GEMS and Irvine cultur...

Companies [908 Associated Companies listed on BioPortfolio]

Reilly Industries

I want to take this opportunity to welcome you to Reilly Industries. In the last few years we have made big changes at Reilly. Reilly is a dynamic firm concentrating on growth in the fields of healt...

O'Reilly Media, Inc.

O'Reilly Media was originally a technical writing consulting company named O'Reilly & Associates. In 1984, we started retaining rights to manuals we created for Unix vendors. Our books were grounded i...

Reilly Pozner LLP

HealthLeaders Media

HealthLeaders Media, a division of HCPro, Inc., is a leading multi-platform media company dedicated to meeting the business information needs of healthcare executives and professi...

Lumina Media

Lumina Media is a leading media company that connects brands with passionate audiences of enthusiasts by providing iconic content across all platforms. With extensive reach and ex...

More Information about "O'Reilly Media, Inc." on BioPortfolio

We have published hundreds of O'Reilly Media, Inc. news stories on BioPortfolio along with dozens of O'Reilly Media, Inc. Clinical Trials and PubMed Articles about O'Reilly Media, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of O'Reilly Media, Inc. Companies in our database. You can also find out about relevant O'Reilly Media, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record